Personal and Home Care Products
CIRS Group
Chemicals
Cosmetic
Food
Medical Devices
Agrochemicals
CIRS Testing
Carbon Neutrality
Search

China New Ingredient Filing Status: Five New Cosmetic Ingredients Filed

from CIRS by

Based on data retrieved from China’s National Medical Products Administration (NMPA), five new cosmetic ingredients have been filed between January 15 and 23, 2025. Detailed information is provided in the table below. At present, the associated technical specifications have not been made public, and the ingredients have not yet entered the post-filing monitoring period. As of now, a total of 15 new cosmetic ingredients have been successfully filed in 2026.

Filing NumberStandard Chinese NameFiling DateChinese Name for the FilerFiler Location
国妆原备字20260011籼稻(ORYZA SATIVA SUBSP. INDICA)米提取物2026/1/15Novate (Kunming) Biotechnology Co., Ltd.China
国妆原备字20260012白子菜(Gynura divaricata (L.) DC.)茎叶提取物2026/1/20Guangdong Marubi Biotechnology Co., Ltd.China
国妆原备字20260013谷氨酸改性珍珠粉2026/1/21Hainan Jingrun Pearl Biotechnology Co., Ltd.China
国妆原备字20260014C12-22 醇丙烯酸酯/丙烯酸羟乙酯共聚物2026/1/22Evonik Operations GmbHGerman
国妆原备字20260015N-二氢香豆酰酪胺2026/1/23Fuzhou Bionty Biotechnology Co., Ltd.China

Note: The English names of the companies listed above, located in domestic China, are for reference only. Please refer to the official registered or commonly used names for formal use.

Interpretation of Information on New Cosmetic Ingredient

Indica Rice (Oryza sativa subsp. indica) is a subspecies of cultivated rice in China. It is well-suited for cultivation in tropical and subtropical regions, and was originally distributed across the Indian subcontinent (India, Pakistan, Bangladesh), Sri Lanka, the Indochinese Peninsula, and southern China. In China, it is primarily grown in the tropical regions of South China and the subtropical lowlands south of the Huai River. Compared to japonica rice, indica rice thrives under long daylight conditions and is more tolerant of heat and drought. It has a shorter growth cycle, allowing for two to three harvests per year, and generally yields higher output. The grains are long with low stickiness, and they contain higher levels of protein and amylose.

Gynura divaricata (L.) DC., commonly known as Bai Zi Cai, is a perennial herbaceous plant belonging to the genus Gynura in the family Asteraceae. It is native to Singapore and distributed in northern Vietnam, as well as in regions such as Guangdong and Hainan in China. Research has shown that Gynura divaricata possesses high nutritional value and a pleasant taste. It is rich in bioactive compounds such as flavonoids, polysaccharides, and alkaloids. The plant also has notable medicinal properties. Pungent and mild in nature, the whole plant is used in traditional medicine for clearing heat and detoxifying, relaxing tendons and promoting bone healing, cooling blood and stopping bleeding, lowering blood pressure, blood sugar, and blood lipids, as well as for its anti-cancer, antioxidant, antimutagenic, anti-inflammatory, and antibacterial effects.

China,Cosmetic,Ingredient,Filing,New

CIRS Group launched Global CosIng – A One-Stop Search Tool for Global Cosmetic Compliance Information. You can visit Global CosIng and find out more via the following link: https://globalcosing.chemradar.com/

If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

Our Services

  • China Cosmetics Registration and Filing
  • China New Cosmetic Ingredients Registration and Filing
  • China Toothpaste Filing
  • China Cosmetics Safety and Efficacy Test
  • Being a Domestic Responsible Person
  • Safety Evaluation Report
  • Cosmetic Ingredient Quality and Safety Info Code Application
  • Formula/Label/Ingredient Review
  • Regulatory Consulting/Reporting/Training
  • Custom Clearance

 

  

We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.

Contact Us
+353 1 477 3710 (EU)
+44 20 3239 9430 (UK)
+1 703 520 1420 (USA)
+86 571 8720 6574 (CN)
+82 2 6347 8816 (KR)
+81 070-9365-8022 (JP)